1. "2019"
Formats
  1. Journal Article (2144)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2450)
  2. Solid Tumor Oncology Division (1408)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (937)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5611)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5611)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Noy, A.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia patients at first relapse: A multi-center outcomes analysis
    Meeting Abstract

    Hu, R.; Wei, W.; Gonter-Aubin, K.; Pinilla Ibarz, J.; Kabel, C. C.; Mato, A. R.; Madanat, Y. F.; Khajavian, S.; Shadman, M.; Hanlon, A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Making progress in graft-versus-host disease prophylaxis and microbiome analysis in the Blood and Marrow Transplant Clinical Trials Network: Progress III (1703)/Mi-Immune (1801)
    Meeting Abstract

    Holtan, S.; Bhatt, A. S.; Fraser, R.; Perales, M. A.; Kean, L.; Saber, W.; Hamadani, M.; Logan, B. R.; Bolaños-Meade, J.
    Blood (2019)

    Fulltext@MSK | Save
  • Dose optimization of duvelisib in patients with relapsed or refractory peripheral T-cell lymphoma from the phase 2 PRIMO trial: Selection of regimen for the dose-expansion phase
    Meeting Abstract

    Horwitz, S. M.; Mehta-Shah, N.; Pro, B.; Jacobsen, E. D.; Casulo, C.; Brammer, J. E.; Haney, J.; Youssoufian, H.; Weaver, D. T.; Baglio, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Plasma cell myeloma residual disease quantitation using a next-generation sequencing-based IGH clonal rearrangement assay with the aid of a "spike-in" clonal sequence
    Meeting Abstract

    Ho, C.; Syed, M.; Yu, W.; Petrova-Drus, K.; Yao, J. J.; Moung, C.; Chang, J.; Benhamida, J.; Vanderbilt, C.; Roshal, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Pharmacodynamic effects and immune correlates of response to the CD20/cd3 bispecific antibody mosunetuzumab in relapsed or refractory non-Hodgkin lymphoma
    Meeting Abstract

    Hernandez, G.; Huw, L. Y.; Belousov, A.; Wilson, D.; Koeppen, H.; McCord, R.; Peng, K.; Bartlett, N. L.; Budde, L. E.; Assouline, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • miR-29 maintains the acute myeloid leukemia epigenome by regulating CBX2
    Meeting Abstract

    Ha, C. J.; Hu, W.; Elias, H. K.; Chakraborty, S.; Park, C. Y.
    Blood (2019)

    Fulltext@MSK | Save
  • Monotherapy activity with the first CD20-targeted immunotoxin, MT-3724, in subjects with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Hamlin, P. A.; Musteata, V.; Zodelava, M.; Park, S. I.; Burnett, C.; Dabovic, K.; Williams, E. T.; Higgins, J. P.; Persky, D. O.
    Blood (2019)

    Fulltext@MSK | Save
  • Integration of genetic, transcriptomic, and immune profiles reveals genomically-distinct populations in low-grade lymphomas
    Meeting Abstract

    Hartert, K. T.; Wenzl, K.; Krull, J.; Manske, M.; Sarangi, V.; Larson, M. C.; Anagnostou, T.; McPhail, E. D.; Link, B. K.; Ansell, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Using current clinical markers to define high risk smoldering multiple myeloma: Agree to disagree
    Meeting Abstract

    Hill, E.; Korde, N.; Mailankody, S.; Morrison, C.; Dew, A.; Albert, J. H.; Graap, K.; Maura, F.; Landgren, O.; Kazandjian, D.
    Blood (2019)

    Fulltext@MSK | Save